DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomas.
Ontology highlight
ABSTRACT: Aberrant DNA methylation commonly occurs in cancer cells where it has been implicated in the epigenetic silencing of tumor suppressor genes. Additional roles for DNA methylation, such as transcriptional activation, have been predicted but have yet to be clearly demonstrated. The BCL6 oncogene is implicated in the pathogenesis of germinal center-derived B cell lymphomas. We demonstrate that the intragenic CpG islands within the first intron of the human BCL6 locus were hypermethylated in lymphoma cells that expressed high amounts of BCL6 messenger RNA (mRNA). Inhibition of DNA methyltransferases decreased BCL6 mRNA abundance, suggesting a role for these methylated CpGs in positively regulating BCL6 transcription. The enhancer-blocking transcription factor CTCF bound to this intronic region
SUBMITTER: Lai AY
PROVIDER: S-EPMC2931164 | biostudies-literature | 2010 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA